Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Cantor Fitzgerald Underwriting) (Narrative) (Details)

v3.22.2.2
Stockholders' Equity (Cantor Fitzgerald Underwriting) (Narrative) (Details) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 19, 2022
May 07, 2021
Feb. 24, 2021
Jan. 11, 2021
Dec. 10, 2020
Dec. 08, 2020
Aug. 17, 2022
Jun. 30, 2021
Nov. 25, 2020
Cost related to issuance of shares               $ 4,713,000  
RubrYc Theraputics, Inc. [Member]                  
Number of shares issued 102,354                
Sales Agreement | Cantor Fitzgerald [Member]                  
Number of shares issued   68,672 4,528       175,973    
Proceeds from sale of shares, net of issuance cost   $ 2,995,000 $ 238,000       $ 1,200,000    
Underwritten Public Offering [Member] | Cantor Fitzgerald [Member]                  
Number of shares agreed to be issued, maximum           1,186,441      
Number of shares issued         1,186,441        
Gross proceeds from issuance of common stock         $ 35,200,000        
Cost related to issuance of shares         $ 2,900,000        
Over-Allotment Option [Member] | Cantor Fitzgerald [Member]                  
Number of shares agreed to be issued, maximum           177,966      
Number of shares issued       169,633          
Proceeds from sale of shares, net of issuance cost       $ 4,600,000          
Sales Agreement | Cantor Fitzgerald [Member]                  
Aggregate offering price                 $ 100,000,000